Ryse Health delivers an interdisciplinary Type 2 diabetes treatment program that combines in-person visits at low-cost clinics with tech-enabled virtual care. Its care team includes endocrinologists, diabetes educators, dietitians, behavioral therapists, and health coaches who support personalized care plans. The company uses continuous glucose monitors and a custom app to provide day-to-day support, analytics, and coaching for long-term patient success. Ryse operates clinics in Arlington, VA and Baltimore and was founded in 2021; it is led by CEO Richard Gurley. Ryse raised $6.5 million in a Series A round and intends to use the funds to grow its team, strengthen business operations, form partnerships, and expand into new markets.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2023